Dow Up 0.48% Nasdaq Up 0.43%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
6.78 0.02(0.29%) Aug 19, 4:00PM EDT
Prev Close:6.80
Open:6.78
Bid:5.98 x 200
Ask:9.63 x 100
1y Target Est:12.89
Beta:1.85
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:6.51 - 6.82
52wk Range:6.04 - 13.64
Volume:442,294
Avg Vol (3m):1,124,500
Market Cap:294.10M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACRXDown 0.29%294.10M
BAX40.70B
CFN9.11B
HSP9.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.09
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback